TY - JOUR T1 - Seroconversion rates and measles antibody titers induced by measles vaccination in Latin American children six to 12 months of age. PY - 1983/5/1/pubmed PY - 1983/5/1/medline PY - 1983/5/1/entrez KW - Age Factors KW - Americas KW - Antibodies KW - Biology KW - Correlation Studies KW - Delivery Of Health Care KW - Demographic Factors KW - Developed Countries KW - Developing Countries KW - Diseases KW - Health KW - Health Services KW - Immunity KW - Immunization KW - Immunologic Factors KW - Infant KW - Latin America KW - Measles--prevention and control KW - Medicine KW - Physiology KW - Population KW - Population Characteristics KW - Preventive Medicine KW - Primary Health Care KW - Research Methodology KW - South America KW - Statistical Studies KW - Studies KW - Vaccination KW - Viral Diseases KW - Youth SP - 596 EP - 605 JF - Reviews of infectious diseases JO - Rev Infect Dis VL - 5 IS - 3 N2 - A collaborative study was conducted to determine how 2,042 infants responded serologically to measles vaccination in six study areas and to help define the optimal age for measles vaccination in children of Latin America. The results suggest that local factors affect the seroconversion rate and that a success rate of 90% can be attained if initial vaccination is given at nine to 11 months of age, depending on the area. Post-vaccination titers also varied, and higher titers were generally observed in groups with higher seroconversion rates. SN - 0162-0886 UR - https://www.unboundmedicine.com/medline/citation/6879022/Seroconversion_rates_and_measles_antibody_titers_induced_by_measles_vaccination_in_Latin_American_children_six_to_12_months_of_age_ L2 - http://www.diseaseinfosearch.org/result/4535 DB - PRIME DP - Unbound Medicine ER -